• Bestatin-Related Aminopeptidase Inhibitors in Malaria Resear

  2026-07-13

  The referenced study introduces phebestin, a bestatin analog, as a potent aminopeptidase inhibitor with nanomolar antiplasmodial activity against both chloroquine-sensitive and -resistant Plasmodium falciparum. These findings highlight the therapeutic promise of targeting parasite aminopeptidases and offer valuable methodological insights for translational malaria research.

• Dabigatran Etexilate: Innovation in Oral Anticoagulation The

  2026-07-13

  The reference review details the clinical and pharmacological advances of dabigatran etexilate, the first oral direct thrombin inhibitor, in the management of venous thromboembolism (VTE) and stroke prevention. Its rapid onset, predictable effects, and lack of need for frequent monitoring address longstanding limitations of traditional anticoagulants, marking a significant shift in thromboprophylaxis protocols.

• N1-Methylpseudouridine: Beyond Translation—Assay Design and

  2026-07-12

  Explore how N1-Methylpseudouridine, a leading modified nucleoside, advances mRNA translation and reduces immunogenicity. This article uniquely connects its application to emerging mitochondrial regulation insights, guiding optimal assay design.

• Tetrandrine Alkaloid: Bridging Calcium Signaling and Antivir

  2026-07-10

  Explore how Tetrandrine, a potent natural alkaloid, is redefining the intersection between ion channel modulation and antiviral research. This article offers fresh scientific depth on Tetrandrine’s mechanisms and translational potential for advanced assay design.

• Resveratrol’s Hormetic Rescue of Radiation-Induced Endotheli

  2026-07-09

  This study establishes a robust in vitro endothelial model to examine how resveratrol rescues vascular injury caused by ionizing radiation. By integrating multiple quantitative assays, the research delineates resveratrol's dose-dependent, hormetic effect on DNA repair and tube formation, offering a platform for screening radioprotective agents.

• Clarithromycin as a CYP3A Inhibitor: Mechanistic Insights &

  2026-07-09

  Explore Clarithromycin's role as a CYP3A inhibitor in drug-drug interaction research, with a focus on mechanistic depth and practical assay design. This article uniquely connects CYP3A inhibition to evolving pharmacokinetic strategies and clinical decision-making.

• DNase I (RNase-free): Mechanistic Leverage in Tumor Microenv

  2026-07-08

  This thought-leadership article explores how DNase I (RNase-free) enables translational researchers to model chemoresistance in complex 3D tumor-stroma co-cultures, facilitating high-fidelity RNA extraction and chromatin analysis. Drawing on recent advances in patient-derived organoid systems, it bridges mechanistic insight with actionable workflow guidance and strategic perspectives for next-generation cancer modeling.

• Anlotinib Hydrochloride Suppresses Angiogenesis via Multi-Ki

  2026-07-08

  The reference study demonstrates that Anlotinib hydrochloride, a multi-target tyrosine kinase inhibitor, robustly blocks tumor-driven angiogenesis by suppressing VEGFR2, PDGFRβ, and FGFR1 signaling. These findings advance mechanistic understanding and offer practical protocols for researchers investigating angiogenesis and cancer therapy.

• Monomethyl Auristatin E: Advancing ADC Payloads Against Canc

  2026-07-07

  Explore how Monomethyl auristatin E (MMAE) is redefining the strategy for targeting tumor cell plasticity and resistance in solid cancers. This thought-leadership article integrates mechanistic insights, translational guidance, and the latest evidence—including lessons from nasopharyngeal carcinoma research—to help researchers maximize the clinical impact of MMAE-based antibody-drug conjugates.

• Murine RNase Inhibitor: Advanced RNA Protection in RT-PCR Wo

  2026-07-07

  APExBIO’s Murine RNase Inhibitor offers robust, oxidation-resistant RNA protection, outperforming traditional inhibitors in real-time RT-PCR, cDNA synthesis, and advanced sequencing workflows. Learn how its unique biochemistry translates into superior assay reproducibility and discover practical troubleshooting tips for maximizing RNA integrity.

• Ultrasonically Powered Implantable TTF: Advancing Glioblasto

  2026-07-06

  This study introduces a battery-free, ultrasonically powered implantable Tumor Treating Field (i-TTF) system using shape-engineered BaTiO3 nanoparticle pyramid receivers for localized glioblastoma therapy. Key findings include improved wireless energy transfer and significant anti-proliferative effects in vitro and in vivo, addressing longstanding limitations of external TTF devices.

• Dinaciclib (SCH727965) in Cancer Research: Beyond Cell Cycle

  2026-07-06

  Explore how Dinaciclib (SCH727965) advances cancer research by targeting CDK-mediated cell cycle regulation and apoptosis. This article delivers unique insights into tissue boundary biology and practical assay implications, setting it apart from prior discussions.

• BMP4-GPX4 Axis Mitigates Ferroptosis in Glaucoma Models

  2026-07-05

  This study demonstrates that BMP4-GPX4 signaling alleviates ferroptosis in retinal ganglion cells (RGCs) and improves their differentiation following retinal stem cell (RSC) transplantation in a mouse model of glaucoma induced by high intraocular pressure. These findings suggest a promising therapeutic strategy for neuroprotection and functional restoration in glaucomatous damage.

• WNT5a/GSK3/β-catenin Axis Regulates Muscle FAP Adipogenesis

  2026-07-04

  This study uncovers how the WNT5a/GSK3/β-catenin pathway controls adipogenic differentiation of skeletal muscle fibro/adipogenic progenitors (FAPs), revealing a mechanism underlying muscle fatty degeneration. These insights highlight the potential of Wnt/β-catenin signaling inhibition for modulating cell fate in muscle disease contexts.

• Doxycycline: Applied Workflows in Cancer and Antimicrobial R

  2026-07-03

  Doxycycline stands out as a tetracycline antibiotic with unique dual-action properties, enabling both robust antimicrobial assays and advanced cancer research applications. This guide delivers actionable protocols, troubleshooting strategies, and translational insights, with a focus on APExBIO's high-quality Doxycycline (SKU BA1003) for reproducible results.

16395 records 1/1093 page Next 12345 下5页 Last page